Migraine.

Migraine affects a large global population with recurrent moderate-to-severe head pain and disabling symptoms, involving complex neurovascular and neurosensory pathways.

• Why it matters: Understanding the mechanisms underlying migraine is crucial because it remains a widespread and disabling condition, with current therapies improving patient outcomes but still limited in scope.
• What they did: Researchers have explored the genetic and epigenetic factors influencing migraine pathogenesis, focusing on the interactions within neurovascular networks to identify potential therapeutic targets.
• The result: Insights into these pathways have led to the development of mechanism-based therapies that are transforming clinical practice and significantly enhancing patients' quality of life.